STUDY OF THE ANTITUMOR ACTIVITY OF THE CHLORINE E6 AND VANDETANIB CONJUGATE AS AN AGENT FOR COMBINED PHOTODYNAMIC AND TARGETED THERAPY
- Autores: Krylova L.V1, Peskova N.N1, Volovetsky A.B1, Pronina S.Y.1, Otvagin V.F1, Kuzmina N.S1, Fedorov A.Y.1, Balalaeva I.V1
-
Afiliações:
- Lobachevsky University
- Edição: Volume 15, Nº 3S (2020)
- Páginas: 54-54
- Seção: Articles
- ##submission.dateSubmitted##: 17.01.2023
- ##submission.datePublished##: 15.12.2020
- URL: https://genescells.ru/2313-1829/article/view/122650
- DOI: https://doi.org/10.23868/gc122650
- ID: 122650
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Texto integral
Sobre autores
L. Krylova
Lobachevsky University
Email: lu.krylova@mail.ru
Nizhny Novgorod, Russia
N. Peskova
Lobachevsky UniversityNizhny Novgorod, Russia
A. Volovetsky
Lobachevsky UniversityNizhny Novgorod, Russia
S. Pronina
Lobachevsky UniversityNizhny Novgorod, Russia
V. Otvagin
Lobachevsky UniversityNizhny Novgorod, Russia
N. Kuzmina
Lobachevsky UniversityNizhny Novgorod, Russia
A. Fedorov
Lobachevsky UniversityNizhny Novgorod, Russia
I. Balalaeva
Lobachevsky UniversityNizhny Novgorod, Russia
Bibliografia
- Otvagin V.F. et al. Water-Soluble Chlorin/Arylaminoquinazoline Conjugate for Photodynamic and Targeted Therapy // J. Med. Chem. 2019; 62, 11182-11193.
Arquivos suplementares
